EDN1 and coronary artery disorder: CAD patients with impaired kidney functions with intermediate and high ET‐1 levels also had a higher MACE risk, with SHR of 3.509 (95% CI 1.841–6.689, p < 0.001) and 6.346 (95% CI 3.444–11.696, p < 0.001), respectively.